Preliminary results are presented of a prospective study of patients who after a first seizure were treated by avoidance of seizure-precipitating factors. Thirty patients have been enrolled of whom 13 (43.3%) already had had a relapse before study onset. Twenty-three patients have been followed for 12 to 102 months, and of these a total of 7 relapses were observed. The recurrence rate in the first year of follow-up was 17.4%, much below the rate expected from the previously observed relapses. Mostly, the relapses were caused bythe same precipitating factors as before. The risk of relapse was not influenced by drug treatment, electroencephalogram findings, focal signs, and positive antecedents, but there was a non-significant trend of previous relapses to increase this risk. The observed seizure recurrences with antiepileptic drug treatment indicate that, if drugs are prescribed, a careful choice of medication is necessary even after a single seizure, and low-dose therapy may not be sufficient. However, careful evaluation of individual factors precipitating the first seizure(s), and Careful subsequent avoidance of these factors seems to be a more efficient therapeutic strategy than pharmacotherapy.
INTRODUCTION
Various recent studies have shown that, after a first epileptic seizure in adolescents and adults, recurrences are more frequent than previously believed. The question whether antiepileptic drug (AED) treatment should always be given following a single seizure is therefore being actively debated. Attempts have been made to define patients with higher and with lower risks of recurrence: one study 1 recommended AED treatment if the electroencephalogram (EEG) showed epileptiform discharge.
Several studies were able to compare medicated and unmedicated groups of patients. Annegers et al. 2 reported a cohort of 424 patients of whom 60.6% were prescribed drugs. The risk of seizure recurrence was equal for medicated and unmedicated patients after 1 year both for idiopathic (29 vs. 25%) and remote symptomatic (61 vs. 50%) cases, whereas after 5 years the idiopathic patients were at a higher risk of recurrence when drugs had been prescribed (60 vs. 41%; remote symptomatic patients: 80 vs. 76%). In the study of Hopkins et al. 3 , AEDs were prescribed to 41 of 306 adults with first seizures, and no drugs given to 265. Both groups did not differ significantly in the rate of recurrence.
Hauser et al. 4 followed 208 patients of whom 80% were recommended continuous AEDs. These showed a modest but non-significant increase in recurrence risk compared with the untreated patients. However, more in keeping with expectations, Hart et al. 5 found a slightly reduced recurrence risk in those 15% of a total of 564 patients who received drug treatment after a first seizure. In all these studies, the decision for or against medication was left to doctors in charge and not influenced by the investigators. In a randomized multicentre trial 6 comparing medicated and non-medicated patients, however, medication reduced the risk of relapse from 41 to 17% after 1, and from 51 to 25% after 2 years of follow-up. The overall relapse rate in this study is considerably lower than in the British investigations, probably because the purpose of the study required exclusion of patients with a seizure relapse before their first clinical interview, a group with a particularly high risk of recurrence 7.
There are several reasons why the prescrip-tion of AEDs after a single seizure may not be as effective in preventing recurrences as the prescribing physician probably expects. Experience does not teach us the right dose or the correct plasma level. A priori, one would tend to prescribe a low rather than a high dose in order to not expose the patient to unnecessary unwanted effects. Would patients after a single seizure be more likely to belong to the groups which respond to a small AED dose? This, however, may be an incorrect assumption. It may also be difficult to establish AED compliance with somebody who has lust once blacked out'. In the studies, successful prevention of recurrences in some cases may be outweighed by withdrawal seizures due to non-compliance in others. In one prospective study 6, 41 of 204 medicated patients (20%) discontinued medication on their own accord, and 11 of them (27%) had a relapse. Finally, the choice of drug after a first seizure can be difficult, and may turn out to have been wrong. Can we do better than this? Are drugs the only possible means of preventing further seizures?
The question of what provokes the first seizure is not uniformly dealt with in the literature. Some studies exclude all provoked seizures, others some, still others none. More importantly, there is no uniform definition of seizure provocation. Seizures occurring 'in the context of uncertain precipitants such as sleep deprivation or "stress" were considered unprovoked' by Hauser et al. 4 Others s-l° consider lack of sleep as a potent and common seizure precipitant. Even if we have not yet discovered many of the provoking factors, some epileptologists are prepared to accept that provocation of seizures may be the rule H. If a seizure precipitant has been identified, an attempt can be made to avoid it in the future. This does not only apply to first seizures, and has indeed long been a central part of the counselling we give patients with epilepsy. Recently, we have begun to apply this in a more uniform way with all patients who are seen after a first seizure, and to follow them prospectively.
This paper reports preliminary results of this longitudinal study.
PATIENTS AND METHODS
In this study, all patients were included who made an appointment following a first clearly and unmistakenly described epileptic seizure, the 'index seizure' of this study. This was not necessarily the only seizure the patient had had. In some, the first observation of a welldescribed seizure clarified an earlier event which had remained undiagnosed. Others had suffered recurrences between the index seizure and the first interview at the clinic. They were all included. The only exclusion criteria was if neurological and ancillary investigations revealed a progressive or acute symptomatic aetiology including chronic alcohol or substance abuse.
The patients in this study are not an unbiased group. Patients with first seizures usually do not come to a fourth level epilepsy centre although some of the patients in this study were recruited from our emergency room. The majority were transferred from their physicians or came by themselves for a second opinion about the diagnosis, the necessity to take drugs, or their ability to drive.
Great care was taken to exclude the possibility that the patients already had epilepsy, and that the apparent first seizure was only the first obvious seizure. This included history taking with specific questions about some of the more common auras and of myoclonicjerks. If a patient's EEG presented generalized Spike Wave (SW) activity, a video EEG was performed with tests of responsiveness during SW activity. I have not counted these instances but, as a rough estimate, for about every two patients included in the study there was one with a presumed first seizure who had to be excluded because he or she clearly already suffered from unrecognized but established epilepsy.
On 30 June 1994, the study comprised a total of 30 patients (Table 1) who have been followed for an average of 30.4 months (range 2-102).
The first interview with these patients and, if possible, their relatives was extensive. It included a detailed analysis of the immediate situation in which the seizure(s) had occurred, and of the days and weeks preceding the seizure. The purpose of this was to discover specific seizure precipitating factors such as flashing lights, as well as non-specific provocants such as sleep withdrawal, important life events and all factors which the patients believed to have contributed to the seizure. In every case, an attempt was made to reach a hypothesis acceptable to both patient and doctor on what had provoked the seizure. Frequently, the patients and relatives would suggest 'stress' as the cause of the seizure. This was only accepted in case of convincingly defined situations of quite unusual physical or psychic strain. Table  2 sums up all precipitating factors thus identified. The total number is higher than 30 because, frequently, more than one factor was present. There was only one patient with no convincing provocation whatsoever. All patients received detailed counselling following a semi-structured schema where the following points were made clear:
The event was an epileptic seizure
--
A single seizure does not yet mean that the diagnosis is 'epilepsy'
It means, however, that there is a high risk that epilepsy will develop unless substantial countermeasures are taken. I usually The seizure means temporary unfitness for driving
The patients were informed about antiepileptic drug treatment (its minimal duration and the necessity of strictly regular intake of drugs; their effectiveness, safety, and possible untoward effects). The patients were invited to make their own decision for or against drug treatment. If they asked for advice it was usually suggested that they continued medication if they were already taking some, and not to start if they were not already taking it. As a consequence of the individual hypothesis about seizure precipitation (see above), strategies for its future avoidance were discussed in detail. These always included regular sleep-wake habits, and cautious use of, or abstinence from, alcohol.
The main points of advice were summed up in a memo 12 which was given to the patients who were requested to take it home to read and come back with any additional questions which might arise. During follow-up, patients were seen as out-patients at individually determined intervals. Usually, there were two to four interviews in the first year and one to two in the following years.
RESULTS
Of the total of 30 patients who have been enrolled until 30 June 1994, 23 have been followed for over 1 year, and their results are reported. Seven have so far had a relapse ( Table 3 ). The relapse rate in the first year of follow-up was 4 of 23 (17.4%), much lower than the retrospective relapse rate of 47.8% in the same patients. Three relapses occurred in the second, third, and ninth year of follow-up.
In four cases, the relapse consisted of a single seizure. Twenty patients (87%) were seizure free for more than 12 months at their last visit.
Relapses were not related to any of the following factors: antiepileptic drug treatment; epileptiform EEG discharge; known antecedents; or focal signs in seizure semiology or EEG. There was a non-significant trend to an increased risk for relapse if there had been previous relapses (Table 3) .
All relapses but one were again caused by provocative factors, usually the same as the previous one (Table 4) .
A total of 11 patients had been prescribed drugs before the start of the study. Five had received valproic acid (VPA), and were still on it. Four had received carbamazepine (CBZ), and two were still on it whereas one had been switched to VPA because with CBZ he was photosensitive with generalized SW. The last patient put on CBZ was switched to phenytoin (DPH) following a severe allergic reaction. One patient had been given DPH which, after a seizure relapse during intermittent light stimulation in the EEG at a serum level of 8.6 I~g/ml was changed to VPA which had to be discontinued because she developed severe alopecia and tremor (plasma levels unknown). One patient had received treatment with an unknown drug abroad following her first seizure, and this was discontinued after an allergic reaction. Thus, of a total of 14 previous medications, three had to be abandoned due to unwanted effects, and two choices had been inappropriate.
Of the 11 patients who had been prescribed drugs, two decided against medication, and had no seizure recurrence. Nine decided for medication. Three relapses occurred in spite of drug therapy, and none of them were due to non-compliance with the medication.
Patient 1
A 21-year-old male was treated with CBZ after two idiopathic non-focal generalized tonicclonic (GTC) seizures both precipitated by reduced sleep, with no EEG abnormalities even in multichannel 48-hour monitoring. In the second year of follow-up, a third GTC seizure occurred during a febrile respiratory infection. The postictal CBZ level of 3.9 i~g/ml was only slightly below his habitual levels of about 5 txg/ml. A post-ictal EEG revealed abundant generalized spike-wave discharges. Medication was changed to VPA, and he has now been seizure free for 21 months.
Patient 2
A 22-year-old female had two cryptogenic GTC seizures with an indistinct aura 5 days apart in a phase of insomnia due to serious probi.ms with her job. EEGs and imaging studies were unrevealing. She was treated with DPH at serum levels of 8-9 ixg/ml. Three months later, she had another GTC seizure with an aphasic aura when her husband had left her because of the seizures, and she again became sleepless. Her post-ictal DPH level was 8.6 txg/ml. DPH was increased to levels of 17-20t~g/ml. Because of ongoing psychological problems she was advised to start psychotherapy (for a detailed history see Wolf12). She has now been seizure free for 2.5 years, still on the same dose of DPH.
Patient 3
A 30-year-old male with a past history of febrile convulsions was treated with VPA (plasma levels of 60-80 ~g/ml) after he had had, 1 month apart, two primarily generalized TCS during sleep at the end of 2 months with a heavily increased work load, lack of sleep, and too much alcohol. His EEG was normal. More than 2 years later, he had a complex focal seizure with oral automatisms described by his wife, after a quarrel and a night of disturbed sleep. Drug intake had been regular, counterchecked by his wife. His treatment was changed to CBZ, and he has now been free of seizures for 8 months.
In five of nine patients who were on a drug at study onset, the drug was discontinued after periods of 4 months to 2 years and, in one patient, after 7 years. Only one of these patients had a relapse.
Patient 4
This 19-year-old male, a fire brigade volunteer, had a twilight state probably caused by absence status, at the end of a long night of fire fighting. His EEG presented generalized SW discharges, and he was put on VPA. This treatment was reduced very slowly over 7 years because of repeated SW increase after dose reductions. One year after discontinuation of VPA, he had his second, very similar seizure when he participated, against my advice, for the second time again in a night's fire fighting. We agreed not to re-start drug treatment but to rely again on sleep regulation. He has remained seizure free since.
Of the 14 patients who were not treated with drugs, three had a relapse, and drug treatment was started in two of them.
Patient 5
A 29-year-old female saw me after her third primarily generalized TCS in 1.5 years. At the two previous occasions, the diagnosis had remained open due to insufficient observation, and she was undergoing psychotherapy because a psychogenic problem had been assumed. All seizures had been preceded by lack of sleep, and one occurred during a heated 91 telephone conversation with her mother. She has generalized SW discharges on her EEG. She decided against drug treatment but proved unable to avoid sleep withdrawal due to her neurotic problems (she is still undergoing psychotherapy). Drug treatment was begun after her seventh seizure.
Patient 6
A 10-year-old girl, the only child in the cohort, whose mother is under my treatment for a benign cryptogenic focal epilepsy starting as an adult. She is the only patient where no precipitating factors could be discovered for both her GTCS which occurred at an interval of 3 months. Whereas detailed investigations after the first seizure had revealed photosensitivity on the EEG as the only abnormality, reinvestigation after the second seizure discovered absences with impaired consciousness and very mild eyelid myoclonus which she did not notice, and which had never been observed. Thus, here, the first and definitely unprovoked GTC seizure marked the onset of juvenile absence epilepsy. The patient was treated with VPA 300 mg (serum levels 20-25 ~g/ml), and has been seizure free with normalized EEG for 2.5 years.
Patient 7
An 18-year-old female was seen after two cryptogenic GTC seizures with an interval of 8 months, both preceded by lack of sleep. Her EEG showed generalized SW, and right temporal sharp waves. Her third seizure occurred 11 months later during a video game, in the absence of other provocative factors. A fourth seizure, 3 months later, was again precipitated by an extraordinarily massive sleep withdrawal. She still declined drug therapy, became very sleep disciplined and has now been seizure free for 16 months.
DISCUSSION
The patient group studied here is small enough to keep track of every patient, and analyse the emerging questions in individual detail whenever this is desirable. But it is also prospective and almost big enough for group analysis, and for at least a tentative comparison with other studies. The study is not controlled for the obvious reason that in this type of intervention no placebo is conceivable. However, a retrospective comparison is possible because there was always some delay between the index seizure and enlisting in the study, and patients with recurrences before study onset but after the index seizure were not excluded.
The retrospective relapse rate of these patients was 47.8% (i.e. between the first seizure and enrolment in the study), and the spontaneous prospective relapse rate (i.e. after enrolment in the study) would have been expected to increase rather than decrease. Instead, the rate of relapse fell to 17.4% in the first year of follow-up, after enrolment in the study, which is among the lowest reported in literature. Although a trend towards a higher risk of relapse was noted if the patient had experienced more than one seizure, there was, thus, a considerable overall decrease of risk which can only be ascribed to the nonpharmacological therapy reported here because this was the only consistent intervention. Drug therapy, EEG findings, historical data, and focal signs all had no influence on the relapse rate. This is at variance with the findings of van Donselaar et al. 1 who found that the risk of relapse was twice as high if their patients had epileptiform activity in their EEGs compared with those that had not. However, it is not sufficiently clear if this always was subclinical discharge, and that study may easily have included patients with their first GTC but chronic non-convulsive seizures. The latter can be extremely difficult to rule out.
Our findings concerning drugs are in accord with the part of the literature which reports no influence of AED treatment on the prognosis after first seizures z-4 whereas other authors found such a difference ~'6. Only in the Italian collaborative study of first tonic-clonic seizures 6 were the results with medication equally as favourable as here. However, that study only comprised 21% with remote previous seizures, and none with recurrences between index seizure and first interview, so that a better prognosis than in our group could have been expected. That study is otherwise difficult to compare with the present one because one third of the study population were children who had relapses more frequently but were not analysed separately. The authors also make it clear that they could not reliably exclude the possibility of preceding or ongoing nonconvulsive seizures, which may account in part for the higher relapse rate they found in untreated patients.
In the majority of studies, the relapse rate in patients treated with drugs is alarmingly high, much higher than in many common epilepsy syndromes, and needs an explanation. Unlike in patients with established epilepsy where drug treatment may be titrated against seizure recurrence, after a first seizure it is of paramount importance that any additional seizures are avoided if possible.
The first of three probable reasons why drug treatment after a first seizure is less effective than desired is the lack of clues about the adequate dose or serum level needed. Prima facie, it might be expected that these patients would respond to low levels because they have had so few seizures. However, it is not known whether the total number of seizures is a factor related to individual therapeutic thresholds, and the relapses which we observed are not in favour of this hypothesis as they occurred at drug levels in the low-medium to medium range. The Italian study 6, where the results of drug treatment are good, required the plasma levels to be in the 'therapeutic', i.e. medium range.
Second, drug treatment may fail due to noncompliance as patients after only a single seizure may not take their situation seriously enough. This, however, can be ruled out as a cause in the present study where great pains were taken to make the patients aware of their condition.
The third difficulty with drug treatment following a first seizure is the choice of drug. Many contemporary authors try to make us believe that there is practically no difference in the effectiveness of the major AEDs, at least in newly diagnosed cases. Our results do not confirm this. Retrospectively, two medications of CBZ and DPH in photosensitve patients had to be abandoned due to lack of effect. Prospectively, in patient 1, CBZ in the medium range did not prevent a seizure relapse in the presence of generalized spikes and waves, and in patient 3, VPA in the medium range similarly did not prevent a focal seizure relapse. For both patients who needed their cars for their jobs, these failures were most embarrassing. Although these are isolated findings, they cast methodological doubt on the abovementioned studies whose designs would not have detected delayed failures like these where the relapses occurred beyond the first year of follow-up, and the treatments would have been wrongly rated as successful.
Our results, despite the comparatively few recurrent seizures, are in clear accord with the concept that CBZ is the first choice drug for focal, and VPA for generalized seizures and photosensitivity.
The principal message of this study however, is that the question which has been so long and fervently discussed, whether drug therapy should be started after a first seizure or not, is the wrong question to ask or, at best, is a question of marginal importance. There are situations (e.g. frequent EEG discharges, or a patient for whom an additional seizure could have catastrophic social consequences) where the doctor or the patient or both may feel better when a drug is prescribed, and hopefully no great harm is caused provided the patient takes the drug regularly (although serious side effects may occur, there is always the additional risk of possible withdrawal seizures, and nobody knows how long such treatment should be continued, the correct drug and dose may be difficult to find, drug treatment probably does not influence the prognosis very much, and drug treatment alone certainly gives far from satisfactory results).
To reduce the risk of seizure relapse as much as possible, it seems to be much more worthwhile to undertake a thorough analysis of all factors which may have contributed to the precipitation of the first, rarely unprovoked, seizure to make patients unmistakingly aware of the risks indicated by the event, and to teach them how they can avoid provocative factors in the future. Individually, this may be rather difficult. The majority of patients are young, and this is often their first serious problem in life. Initially, it is difficult to accept and cope with, but quite a few of the patients reported here went into a second stage where they felt they had got control of the situation, and found they had become more mature during the process. During the prospective phase of this study, it has become increasingly clear to me that the printed memo 12 given to the patients, the repeated discussion of the points included in it, and the participation of family members and friends in the talks are of invaluable importance.
In the long run, some patients found their experiences as a consequence of their first seizure to have changed their attitudes in such a way that they would rather not have missed it. Individually, a first seizure may be indicative
